Literature DB >> 18237790

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study.

Alexander M Strasak1, Cecily C Kelleher, Larry J Brant, Kilian Rapp, Elfriede Ruttmann, Hans Concin, Günter Diem, Karl P Pfeiffer, Hanno Ulmer.   

Abstract

BACKGROUND: The role of serum uric acid (SUA) as a risk factor for cardiovascular disease (CVD) remains controversial. Little is known about its predictive value for mortality from congestive heart failure (CHF) and stroke, particularly in elderly, post-menopausal women.
METHODS: The relation of SUA to risk of death from total CVD, CHF, stroke and coronary heart disease (CHD) was examined prospectively in a large cohort of 28613 elderly Austrian women (mean age 62.3 years), followed-up for a median of 15.2 years. Adjusted Cox proportional hazards models were calculated to evaluate SUA as an independent predictor for fatal CVD events.
RESULTS: SUA in the highest quartile (>or=5.41 mg/dL) was significantly associated with mortality from total CVD (p<0.0001), showing a clear dose-response relationship; the adjusted hazard ratio (95%CI) in comparison to the lowest SUA quartile was 1.35 (1.20-1.52). In subgroup analyses SUA was independently predictive for deaths from acute and subacute (p<0.0001) and chronic forms (p=0.035) of CHD, yielding adjusted hazard ratios for the highest versus lowest SUA quartile of 1.58 (1.19-2.10) and 1.25 (1.01-1.56), respectively. SUA was further significantly related to fatal CHF (p<0.0001) and stroke (p=0.018); the adjusted hazard ratios for the highest versus lowest SUA quartile were 1.50 (1.04-2.17) and 1.37 (1.09-1.74), respectively.
CONCLUSIONS: These findings, for the first time, demonstrate that SUA is an independent predictor for all major forms of death from CVD including acute, subacute and chronic forms of CHD, CHF and stroke in elderly, post-menopausal women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18237790     DOI: 10.1016/j.ijcard.2007.11.094

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  65 in total

1.  Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.

Authors:  Richard J Johnson; Miguel A Lanaspa; Eric A Gaucher
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 2.  Hyperuricemia and risk of stroke: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Rheum       Date:  2009-07-15

3.  Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort.

Authors:  Angelo L Gaffo; Jeffrey M Roseman; David R Jacobs; Cora E Lewis; James M Shikany; Ted R Mikuls; Pauline E Jolly; Kenneth G Saag
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

4.  Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality.

Authors:  George N Ioannou; Edward J Boyko
Journal:  Atherosclerosis       Date:  2012-10-22       Impact factor: 5.162

5.  Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.

Authors:  Hongchao Zheng; Ning Li; Yueyou Ding; Peizhi Miao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Authors:  Peter Higgins; Jesse Dawson; Matthew Walters
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-11-04

7.  Urate oxidase knockdown decreases oxidative stress in a murine hepatic cell line.

Authors:  Beth M Cleveland; Stephen S Leonard; Hillar Klandorf; Kenneth P Blemings
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

8.  Plasma uric acid concentrations and risk of ischaemic stroke in women.

Authors:  M C Jiménez; G C Curhan; H K Choi; J P Forman; K M Rexrode
Journal:  Eur J Neurol       Date:  2016-04-09       Impact factor: 6.089

9.  Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial.

Authors:  Charlotte Andersson; Peter Weeke; Bente Brendorp; Lars Køber; Emil L Fosbøl; Arya M Sharma; Nick Finer; Ian D Caterson; Richard A Rode; Philip T James; Christian Torp-Pedersen
Journal:  Nutr Metab (Lond)       Date:  2009-10-14       Impact factor: 4.169

Review 10.  Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Authors:  Angelo L Gaffo; N Lawrence Edwards; Kenneth G Saag
Journal:  Arthritis Res Ther       Date:  2009-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.